Last update:

Oncology & Cancer news

Oncology & Cancer

Localized IL-12 delivery reshapes CAR-T safety in solid tumors

An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding interleukin 12 strategy that lets CAR-T cells treat prostate cancer in mice while curbing previously ...

Oncology & Cancer

Common cholesterol drug might protect against 'chemo brain'

The most common cholesterol drug around might help protect cancer patients from "chemo brain."

Oncology & Cancer

Scientists uncover new driver of ovarian cancer spread

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly improve the outlook for women diagnosed with this aggressive disease.

Oncology & Cancer

Living tumor-on-a-chip exposes how cancers block immune attacks

For a little over two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a powerful new way to treat cancer. By extracting patients' T cells, re-engineering them to recognize tumor antigens, and infusing ...

Oncology & Cancer

An understudied type of breast cancer poses a lurking threat

University of Colorado Cancer Center member Matthew Sikora, Ph.D., is a national leader in research into an understudied subtype of breast cancer that's on the rise in American women, is often more difficult to detect than ...

Oncology & Cancer

Shampoo-like gel could help chemo patients keep their hair

Cancer fighters know that losing their hair is often part of the battle, but Michigan State University researchers have developed a shampoo-like gel that has been tested in animal models and could protect hair from falling ...

Oncology & Cancer

Investigators create urine-based test to ID prostate cancers

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers present in urine. This approach ...

Medical research

Pioneering strategy may keep breast cancer from coming back

A first-of-its-kind clinical trial has shown it's possible to identify breast cancer survivors who are at higher risk of their cancer coming back due to the presence of dormant cancer cells and to effectively treat these ...